middle.news
SomnoMed Surges 20% in Q2, Raises FY25 Revenue Target to $105M
8:44am on Friday 24th of January, 2025 AEDT
•
Healthcare
Read Story
SomnoMed Surges 20% in Q2, Raises FY25 Revenue Target to $105M
8:44am on Friday 24th of January, 2025 AEDT
Key Points
Q2 FY25 revenue up 19.8% to $28.5 million
FY25 revenue guidance raised to approximately $105 million
EBITDA forecast set between $7 million and $9 million
Cash balance strengthened to $18.5 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Somnomed (ASX:SOM)
OPEN ARTICLE